Skip to main content
. 2018 May 29;103(7):2468–2477. doi: 10.1210/jc.2017-02629

Table 2.

Clinical Characteristics of Thyroid Cancer Survivors Stratified by CVD Diagnosis 1 to 5 Years After Cancer Diagnosis (N = 3822)

Characteristic Total (N = 3822) CVD 1-5 Y After Cancer Diagnosis
Yes (n = 1719) No (n = 2103) P Value
Histologic type 0.43
 Papillary carcinoma 3510 (91.8) 1564 (91.0) 1946 (92.5)
 Anaplastic carcinoma 6 (0.2) 4 (0.2) 2 (0.1)
 Follicular carcinoma 240 (6.3) 118 (6.9) 122 (5.8)
 Medullary carcinoma 49 (1.3) 24 (1.4) 25 (1.2)
 Other 17 (0.4) 9 (0.5) 8 (0.4)
Treatment 0.40
 Surgery only 1790 (46.8) 809 (47.1) 981 (46.7)
 Surgery and radiation 2006 (52.5) 895 (52.1) 1111 (52.8)
 Other 26 (0.7) 15 (0.9) 11 (0.5)
TSH suppression therapy 0.002
 No 2881 (75.4) 1254 (73.0) 1627 (77.4)
 Yes 941 (24.6) 465 (27.0) 476 (22.6)
CCI score at baseline < 0.0001
 0 1543 (40.4) 247 (14.4) 1296 (61.6)
 ≥1 2279 (59.6) 1472 (85.6) 807 (38.4)
No. of cancers 0.17
 1 3456 (90.4) 1542 (89.7) 1914 (91.0)
 ≥2 366 (9.6) 177 (10.3) 189 (9.0)

Data presented as n (%).